Steven Butcher, PhD Dr Butcher serves as an Operating Partner of Advent Life Sciences Fund II LP. Dr Butcher has over 20 years of experience in both small biotech and larger pharmaceutical companies. He has a strong track record in pre-clinical research and development, as well as business and corporate development. Dr. Butcher was a founder of the Fujisawa Institute of Neuroscience in 1991 and served as its Scientific Director. He joined Pharmacia and Upjohn AB in 1997 as Head of Biochemistry, and from 1998 was Director of Target Discovery for Pharmacia AB in Sweden.
He joined Gemini Genomics (Cambridge, UK) in 2000 as VP Research, and then served as CSO of BioImage A/S (Denmark) from 2003 to 2006. Dr Butcher joined TopoTarget A/S (Denmark) in 2006 and served as Chief Operating Officer and VP, Corporate Development. More recently, he was Chief Operating Officer at CoCo Therapeutics Ltd. Dr. Butcher is originally a pharmacologist with a Ph.D. in Pharmacology from University of Southampton, UK